<DOC>
	<DOCNO>NCT02532309</DOCNO>
	<brief_summary>This 2-year , open-label , randomize study evaluate efficacy Rosuvastatin dose adjustment LDL-C level compare 5mg maintenance dose chinese patient Carotid Atherosclerosis .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Rosuvastatin Treatment Carotid Atherosclerotic Plaques</brief_title>
	<detailed_description>This 2-year , randomize , open-label , prospective , parallel-group study . It hold China-Japan Friendship Hospital . Subjects Carotid Atherosclerosis Plaques meet inclusion none exclusion criterion randomize 1:1 ratio receive treatment rosuvastatin ( 5 mg , 10mg , 20mg ) dose adjustment LDL-c level fix dose 5 mg . The study consist two phase : Screening/Baseline period（-1to week 0）and Follow-up period ( 0 month 24 ) . The follow-up period comprise seven visit .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Plaque , Atherosclerotic</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Subjects legal guardian understand sign write informed consent form ; LDLC≥100mg/dl（2.6mmol/l） . Subjects carotid atherosclerotic noncalcified plaque determine color Doppler ultrasound carotid . ( Plaque define limited intima medium thickness≥1.5mm , accord procedure vascular ultrasound examination 2009 Chinese Journal Ultrasonography ) Subjects treated statin , one treat antihyperlipidemics 3 month within 12 month prior screen . Subjects know allergic study medication , component . Uncontrolled hypothyroidism define systolic blood pressure ( SBP ) &gt; 180 mmHg diastolic blood pressure ( DBP ) ＞100 mmHg . Concomitant severe frequent arrhythmia , Atrial Fibrillation , second third degree Atrioventricular Block , Sick sinus Syndrome etc . Alanine aminotransaminase ( ALT ) /or Aspartate aminotransferase ( AST ) &gt; 1.5×ULN ( upper limit normal ) . Subjects myopathies，or value Creatine kinase &gt; 1.5×ULN ( upper limit normal ) . Concomitant chronic wasting disease , whose life span anticipate long 2 year . Pregnant nursing woman , subject Pregnant plan study . Cognitive impairment , may affect obtain informed consent participate study procedure . Unwilling receive treatment examination outline protocol .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Rosuvastatin</keyword>
	<keyword>Carotid Atherosclerosis plaque</keyword>
	<keyword>Crestor</keyword>
	<keyword>Rosuvastatin calcium</keyword>
</DOC>